We are live on ! Find out more
WSC

Wellington Shields & Co Portfolio holdings

AUM $392M
1-Year Est. Return 30.65%
This Fund
S&P 500
This Quarter Est. Return
+13.27%
1 Year Est. Return
+30.65%
3 Year Est. Return
+75.6%
5 Year Est. Return
+100.7%
10 Year Est. Return
+459.98%
AUM
$440M
AUM Growth
+$211M
Cap. Flow
+$187M
Cap. Flow %
42.6%
Top 10 Hldgs %
61.34%
Holding
297
New
18
Increased
65
Reduced
72
Closed
5

Top Buys

Rank Stock Value
1
FLO icon
Flowers Foods
FLO
+$187M
2
PEBO icon
Peoples Bancorp
PEBO
+$1.58M
3
DVN icon
Devon Energy
DVN
+$582K
4
GEF.B icon
Greif Class B
GEF.B
+$403K
5
CF icon
CF Industries
CF
+$386K

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$2.24M
2
AMZN icon
Amazon
AMZN
+$1.18M
3
AAPL icon
Apple
AAPL
+$429K
4
HD icon
Home Depot
HD
+$305K
5
FNKO icon
Funko
FNKO
+$267K

Sector Composition

Rank Sector Weight
1 Consumer Staples 47.74%
2 Healthcare 12.59%
3 Technology 10.36%
4 Financials 7.44%
5 Industrials 7.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLO icon
1
Flowers Foods
FLO
$1.62B
$197M 44.73%
6,849,098
+6,644,368
+3,245% +$187M
MSFT icon
2
Microsoft
MSFT
$2.84T
$16.2M 3.69%
67,746
+381
+0.6% +$91.4K
AAPL icon
3
Apple
AAPL
$4.7T
$14M 3.18%
107,778
-2,999
-3% -$429K
ILMN icon
4
Illumina
ILMN
$29.5B
$12M 2.73%
61,024
JPM icon
5
JPMorgan Chase
JPM
$925B
$6.28M 1.43%
46,858
-982
-2% -$124K
XOM icon
6
ExxonMobil
XOM
$654B
$5.76M 1.31%
52,262
+872
+2% +$93.4K
ABBV icon
7
AbbVie
ABBV
$452B
$5.38M 1.22%
33,317
+694
+2% +$106K
LLY icon
8
Eli Lilly
LLY
$1.05T
$5.04M 1.15%
13,787
+83
+0.6% +$29.4K
HON icon
9
Honeywell
HON
$77.3B
$4.57M 1.04%
22,640
+243
+1% +$46.4K
UNP icon
10
Union Pacific
UNP
$181B
$3.77M 0.86%
18,208
-100
-0.5% -$20.5K
CVS icon
11
CVS Health
CVS
$136B
$3.75M 0.85%
40,229
-2,625
-6% -$253K
PFE icon
12
Pfizer
PFE
$142B
$3.61M 0.82%
70,542
+396
+0.6% +$19K
IBM icon
13
IBM
IBM
$194B
$3.54M 0.8%
25,098
-397
-2% -$54.8K
ABT icon
14
Abbott
ABT
$175B
$3.27M 0.74%
29,780
+1,778
+6% +$184K
BX icon
15
Blackstone
BX
$151B
$2.87M 0.65%
38,656
+854
+2% +$73.8K
JNJ icon
16
Johnson & Johnson
JNJ
$622B
$2.85M 0.65%
16,108
-327
-2% -$56.5K
MRK icon
17
Merck
MRK
$321B
$2.83M 0.64%
25,510
-900
-3% -$92K
SPGI icon
18
S&P Global
SPGI
$124B
$2.81M 0.64%
8,400
GOOG icon
19
Alphabet (Google) Class C
GOOG
$3.9T
$2.75M 0.63%
31,001
+79
+0.3% +$7.54K
BMY icon
20
Bristol-Myers Squibb
BMY
$126B
$2.71M 0.62%
37,665
+425
+1% +$32K
DIS icon
21
Walt Disney
DIS
$161B
$2.67M 0.61%
30,700
+375
+1% +$35.9K
FLR icon
22
Fluor
FLR
$7.39B
$2.65M 0.6%
76,313
BA icon
23
Boeing
BA
$163B
$2.47M 0.56%
12,956
-562
-4% -$91.9K
V icon
24
Visa
V
$667B
$2.42M 0.55%
11,664
+809
+7% +$163K
CVX icon
25
Chevron
CVX
$389B
$2.33M 0.53%
12,973
+309
+2% +$53.9K

Similar funds

Wellington Shields & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Wellington Shields & Co held 297 positions worth $440M, up 92% from $229M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Wellington Shields & Co deployed $187M of net new capital in Q4 2022, opening 18 new positions and adding to 65 existing holdings. Its largest new stake was Peoples Bancorp: 53,830 shares worth $1.52M.

By sector, the portfolio is most concentrated in Consumer Staples at 48% of assets, up from 7.4% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Royalty Pharma, an estimated $2.24M trimmed.

  • Wellington Shields & Co's largest Q4 2022 buy was Peoples Bancorp: 53,830 shares worth $1.52M.
  • Wellington Shields & Co added most to Flowers Foods in Q4 2022, an estimated $187M increase.
  • Wellington Shields & Co's biggest Q4 2022 reduction was Royalty Pharma, cutting an estimated $2.24M.
  • Wellington Shields & Co fully exited Vanguard Short-Term Corporate Bond ETF in Q4 2022, selling an estimated $79K.
  • Wellington Shields & Co's ten largest holdings make up 61% of its $440M portfolio in Q4 2022.
  • Wellington Shields & Co opened 18 new positions and closed 5 in Q4 2022.
  • Wellington Shields & Co's portfolio value rose 92% quarter-over-quarter to $440M.

Based on Wellington Shields & Co's 13F filing for Q4 2022, filed 15 Feb 2023.